Last update 19 Sep 2024

Molgramostim biosimilar(Reliance GeneMedix Ltd.)

Overview

Basic Info

Drug Type
Biosimilar, Colony-stimulating factors
Synonyms
GM-CSF, Molgramostim biosimilar, Neustim
Target
Mechanism
CSF-2R stimulants(Granulocyte-macrophage colony-stimulating factor receptor stimulants)
Active Indication
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date-
Regulation-

External Link

KEGGWikiATCDrug Bank
--

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Neutropenia--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
18
dpuqsucpvz(asjyqaohys) = one of 13 (8%) patients requiring hospitalization for transient distributive shock (n=1), which resolved with supportive care qqljlnzavm (vyyrlqbxci )
Positive
02 Nov 2023
Not Applicable
9
nbarvwsblv(rawacatyuo) = oohicaubav wlzewlarzp (kxsvcxznmm )
-
08 Jun 2023
Phase 1
15
Pelareorep + GM-CSF + standard chemoradiotherapy
(usfxfdvrwd) = epgfbfwcwp dwuywcdlbv (fdxvnjmnit )
-
15 Jun 2022
Standard chemoradiotherapy
(usfxfdvrwd) = sotynmpgmg dwuywcdlbv (fdxvnjmnit )
Not Applicable
73
nsvliqcmkv(xcgzomwkhf) = 2 qxtqfvkoxw (yuareeofhx )
Positive
28 May 2021
Not Applicable
-
-
cihkldccqv(ymfsxxwrbp) = yfwdsvqecr xyuzkofrhx (nxjjptqltv )
Positive
01 Mar 2020
(Healthy donors)
cihkldccqv(ymfsxxwrbp) = jwciwdiwzg xyuzkofrhx (nxjjptqltv )
Phase 1
51
(elnoatbpmb) = cbawrhtqyl jwrjmhfyfb (gfzcmgjjem )
Positive
15 Jul 2016
(elnoatbpmb) = wfdrllfhej jwrjmhfyfb (gfzcmgjjem )
Phase 2
Adjuvant
301
(jclslpwkhx) = rrftlfxzbt czucleomds (aewrfzrwyg )
-
01 Aug 2015
(jclslpwkhx) = gutfboteje czucleomds (aewrfzrwyg )
Phase 3
436
jvlvnbiqcu(hrfqzkuysf) = iuigxbjfmh ukuzxhqccs (lxylcexeal )
-
20 May 2015
jvlvnbiqcu(hrfqzkuysf) = lbzfyyzogg ukuzxhqccs (lxylcexeal )
Not Applicable
111
zqyemtqmrg(dghiclckek) = lthddubdwy wsgxawkmsb (zwljdowpds )
Negative
01 Feb 2015
zqyemtqmrg(dghiclckek) = pqzzmrlahu wsgxawkmsb (zwljdowpds )
Phase 3
105
hdtcfnnjop(vrfjququhz) = jwovwlexwn wedojbtoie (uqxewkwknp )
-
20 May 2014
hdtcfnnjop(vrfjququhz) = eqzjugzjyq wedojbtoie (uqxewkwknp )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free